Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Blueprint Medicines

Explore full profile

Developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases

Cambridge, United StatesFounded 2011Biotech & Life Sciences
Valuation $8.25B Market cap · 2026
Revenue $509M Latest reported FY

At a glance

Founded
2011
Headquarters
Cambridge, United States
Listing
IPO 2015
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News Ringg lands $10M from Peak XV to expand voice AI beyond calls Aug 26, 2026 Market map billionaire funded longevity startups

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later4 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 712 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 7 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 7 startups shown

Former Blueprint Medicines employees who went on to found companies, sorted by Dealroom signal score.

Solve TherapeuticsEst. 2021
Dave JohnsonUnited States
Signal score91
Recludix PharmaEst. 2019
BHBrian HodousUnited States
Signal score71
Nested TherapeuticsEst. 2021
Klaus HoeflichUnited States
Signal score69
Frontier MedicinesEst. 2018
Chris VarmaUnited States
Signal score68
Celsius TherapeuticsEst. 2018
Christoph LengauerUnited States
Signal score63
2 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
12 countries with
team presence
🇺🇸 United States85.9%
🇩🇪 Germany4%
🇨🇭 Switzerland3.7%
🇪🇸 Spain1.6%
🇮🇹 Italy1.4%
Top 5 of 12 shown
Web traffic by country
14K monthly visits
across markets
🇺🇸 United States53.6%
🇮🇳 India17.1%
🇪🇸 Spain7.1%
🇨🇦 Canada6.4%
🇫🇷 France5%
Top 5 markets shown

Patents

Estimated portfolio value
$90M

80 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Blueprint Medicines on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Blueprint Medicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles